Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1234.60

-10.90 (-0.88%)

< Home < Back

Dr. Reddy’s Laboratories informs about press release

Date: 14-06-2022

Dr. Reddy’s Laboratories enclosed a Press Release on ‘Dr. Reddy's Laboratories announces the launch of the generic version of Nexavar (sorafenib) Tablets, USP, 200 mg in the U.S. market’.

The above information is a part of company’s filings submitted to BSE.